In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus

por Mtambo, Sphamandla E., Kumalo, Hezekiel M.
Publicado 2022

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective

por Mtambo, Sphamandla E., Ugbaja, Samuel C., Kumalo, Hezekiel M.
Publicado 2022

Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex

por Mtambo, Sphamandla E., Ugbaja, Samuel C., Mushebenge, Aganze G., Abubakar, Bahijjahtu H., Ntuli, Mthobisi L., Kumalo, Hezekiel M.
Publicado 2022

Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus

por Ugbaja, Samuel C., Mtambo, Sphamandla E., Mushebenge, Aganze G., Appiah-Kubi, Patrick, Abubakar, Bahijjahtu H., Ntuli, Mthobisi L., Kumalo, Hezekiel M.
Publicado 2022

Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation

por Mushebenge, Aganze G., Ugbaja, Samuel C., Mtambo, Sphamandla E., Ntombela, Thandokuhle, Metu, Joy I., Babayemi, Oludotun, Chima, Joy I., Appiah-Kubi, Patrick, Odugbemi, Adeshina I., Ntuli, Mthobisi L., Khan, Rene, Kumalo, Hezekiel M.
Publicado 2023